-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
This article summarizes the recently released guidelines and consensus on urology/urinary tumors at home and abroad for your reference and download
.
Prostate cancer bone metastasis and bone-related diseases clinical diagnosis and treatment expert consensus (2021 version) bone is the most important metastatic site of prostate cancer, more than 70% of advanced prostate cancer patients will have bone metastasis and bone-related events (SREs)
.
Bone metastasis and the resulting SREs, such as spinal cord compression, pathological fractures, etc.
, seriously affect the quality of life of patients
.
At present, there is no unified treatment plan for bone metastasis of prostate cancer.
In view of the current diagnosis and treatment status, combined with clinical practice and related research at home and abroad, the Professional Committee of Urinary and Male Reproductive System Tumors of the Chinese Anti-Cancer Association has formulated the clinic for bone metastasis of prostate cancer and bone-related diseases.
Expert consensus on diagnosis and treatment (2021 version)
.
Download link: http://guide.
medlive.
cn/guideline/24476 Related reading: Professor Ye Dingwei's interpretation of "Expert Consensus on the Clinical Diagnosis and Treatment of Bone Metastasis and Bone-related Diseases in Prostate Cancer (2021 Edition)" 2021 EAU Guidelines: Metastatic Urothelial Carcinoma (Update) The EAU guide is one of the most authoritative guides in the world.
It will be updated every year, and each update has attracted the attention of urologists worldwide
.
Untreated metastatic urothelial carcinoma (mUC) can be divided into three types: suitable for patients with cisplatin-containing regimens, suitable for patients with carboplatin-containing regimens, and not suitable for patients with any platinum-containing regimens
.
This update of the 2021 EAU guidelines mainly involves first-line treatment, second-line treatment and above for metastatic urothelium
.
Download link: http://guide.
medlive.
cn/guideline/24467 Related reading: 2021 EAU Guidelines (Part 2): Second-line and above treatment of metastatic urothelial cancer; 2021 EAU guidelines | Metastatic urothelial cancer Treatment (Part I): First-line treatment of non-muscular invasive bladder cancer expert consensus on bladder perfusion therapy (2021 version) In recent years, the clinical diagnosis and treatment of non-muscular invasive bladder cancer at home and abroad has made great progress, including non-muscular invasive bladder cancer Risk assessment of bladder cancer, choice of bladder perfusion drugs, adverse reactions and treatment experience of bladder perfusion, and clinical research of new bladder perfusion drugs
.
The consensus is based on evidence-based medicine at home and abroad, combined with the current domestic clinical practice and application experience of bladder perfusion treatment for non-muscle invasive bladder cancer, and corresponding discussions and updates are carried out on the basis of the 2019 version of the expert consensus, with a view to improving the current domestic non-muscular invasive bladder cancer.
The clinical standardized treatment of bladder perfusion for muscular invasive bladder cancer provides certain guidance
.
Download link: http://guide.
medlive.
cn/guideline/24477 Chinese urothelial cancer human epidermal growth factor receptor 2 detection clinicopathological expert consensus At present, there is no internationally targeted urothelial cancer HER-2 expression status Standardize testing procedures and interpretation standards
.
The Oncology Pathology Professional Committee of the Chinese Anti-Cancer Association and the Urothelial Cancer Expert Committee of the Chinese Society of Clinical Oncology organize relevant experts based on the clinical practice of HER-2 expression, gene amplification and mutation detection in urothelial cancer, combined with current research progress, The committee members discussed internally, and finally reached a consensus of clinical pathology experts on the detection of human epidermal growth factor receptor 2 for urothelial cancer in China, aiming to standardize the detection standards of urothelial cancer HER-2 and improve the accuracy of interpretation to guide clinical applications
.
Download link: http://guide.
medlive.
cn/guideline/24489 Renal cancer bone metastasis clinical diagnosis and treatment expert consensus (2021 version) bone metastasis is a common metastatic site of kidney cancer, about 30% of metastatic renal cancer with bone metastasis, Bone-related events (SREs) occur in more than 70% of renal cancer patients with bone metastases.
Preventing the occurrence of SREs is one of the main goals of the treatment of renal cancer bone metastases
.
In addition to basic anti-tumor therapy, bone-modifying drugs are also the basic treatment for bone metastases from renal cancer
.
The expert group of the Professional Committee of Urinary and Male Reproductive System Tumors of the Chinese Anti-Cancer Association has reached a consensus to standardize the diagnosis and treatment model for bone metastases of kidney cancer in China, so as to improve the overall treatment level of bone metastases of kidney cancer and benefit more patients
.
Download link: http://guide.
medlive.
cn/guideline/244782021 ESMO clinical practice guide: the application of immunotherapy in early and advanced renal cell carcinoma (updated version) September 2021, the European Society of Medical Oncology (ESMO) released Guidelines for the application of immunotherapy in early and advanced renal cell carcinoma
.
The guidelines mainly focus on recent related content on immunotherapy for renal cell carcinoma
.
Download link: http://guide.
medlive.
cn/guideline/24271 Related reading: ESMO guide: A list of recommendations for early/advanced renal cell carcinoma immunotherapy! Expert consensus on the treatment of benign prostatic hyperplasia with traditional Chinese and Western medicine fusion medicine.
Chinese patent medicines for the treatment of benign prostatic hyperplasia combine syndrome differentiation and treatment with symptomatic treatment.
It has significant clinical effects in improving its symptoms and inhibiting benign prostatic hyperplasia, with obvious advantages
.
Although there are certain advantages in the treatment of BPH with integrated traditional Chinese and western medicine, there is a lack of standardized integrated Chinese and western medicine diagnosis and treatment plan, and the differentiation of syndromes is dogmatic.
It is difficult for western doctors who do not have the knowledge of traditional Chinese medicine to guide the use of Chinese patent medicines based on the consensus of traditional Chinese medicine.
Therefore, it is necessary to formulate This consensus
.
Download link: http://guide.
medlive.
cn/guideline/244632021 CUA Guidelines: Erectile Dysfunction In October 2021, the Canadian Urological Association (CUA) issued guidelines for erectile dysfunction
.
Erectile dysfunction (ED) affects the health and quality of life of patients.
The focus of evaluating ED patients is to determine the reversible and irreversible potential factors
.
This article mainly provides guidance and suggestions for the evaluation and treatment of ED
.
Download link: http://guide.
medlive.
cn/guideline/24336 Phimosis and overlength of the foreskin and foreskin-related diseases.
The consensus of Chinese experts and overlength of the foreskin accounts for a large proportion.
Circumcision is also the most common operation in urology and andrology.
One of them is traditional circumcision, ring ligation and suture circumcision.
Among them, ring ligation and suture circumcision have been widely developed and applied in domestic hospitals at all levels, but There are also problems such as irregular operation and over-treatment.
Standardized diagnosis, treatment and training are important measures to do a good job in circumcision and reduce surgical complications.
We are referring to relevant evidence-based medical clinical data, guidelines and consensus at home and abroad.
On the above, the consensus was compiled to provide appropriate clinical guidance and reference for the diagnosis and treatment of phimosis and foreskin-related diseases for urologists
.
Download link: http://guide.
medlive.
cn/guideline/24460 Chinese Expert Consensus on the Update of Standards for Screening Qualified Sperm Donor Volunteers Initiated with the Evaluation Professional Committee Sperm Bank and Reproductive Andrology Group, organized domestic experts in the field of human sperm bank to establish an expert consensus working group and discussed and wrote repeatedly
.
The content involves all aspects of the examination of sperm donors, including the choice of age, semen parameters, sperm morphological rate of sperm donors, supplementation of the physical examination standards for sperm volunteers, interpretation of 3 contents and 9 criteria for the examination results of sperm volunteers Point
.
Download link: http://guide.
medlive.
cn/guideline/243402021 ICCS consensus document: Neurodevelopmental disorders and urinary incontinence in children and adolescents-attention deficit/hyperactivity disorder, autism spectrum disorder and intellectual disability September 2021, The International Children’s Continence Society (ICCS) has issued a consensus document on neurodevelopmental disorders and urinary incontinence in children and adolescents.
Neurodevelopmental disorders (NDs) are a disabling disease that began to appear early in the statement, mainly due to genetic and neurobiological factors Cause, and have a tendency to persist
.
This article introduces the three most important NDs, including attention deficit/hyperactivity disorder, autism spectrum disorder, and intellectual disability
.
Download link: http://guide.
medlive.
cn/guideline/242522021 EAU Guidelines: Sexual and Reproductive Health-Male Infertility In September 2021, the European Association of Urology (EAU) updated and released the Men’s Sexual and Reproductive Health Guidelines Infertility related content
.
The content involves the epidemiology and pathology of male infertility, diagnostic tests, special considerations and management
.
Download link: http://guide.
medlive.
cn/guideline/24138
.
Prostate cancer bone metastasis and bone-related diseases clinical diagnosis and treatment expert consensus (2021 version) bone is the most important metastatic site of prostate cancer, more than 70% of advanced prostate cancer patients will have bone metastasis and bone-related events (SREs)
.
Bone metastasis and the resulting SREs, such as spinal cord compression, pathological fractures, etc.
, seriously affect the quality of life of patients
.
At present, there is no unified treatment plan for bone metastasis of prostate cancer.
In view of the current diagnosis and treatment status, combined with clinical practice and related research at home and abroad, the Professional Committee of Urinary and Male Reproductive System Tumors of the Chinese Anti-Cancer Association has formulated the clinic for bone metastasis of prostate cancer and bone-related diseases.
Expert consensus on diagnosis and treatment (2021 version)
.
Download link: http://guide.
medlive.
cn/guideline/24476 Related reading: Professor Ye Dingwei's interpretation of "Expert Consensus on the Clinical Diagnosis and Treatment of Bone Metastasis and Bone-related Diseases in Prostate Cancer (2021 Edition)" 2021 EAU Guidelines: Metastatic Urothelial Carcinoma (Update) The EAU guide is one of the most authoritative guides in the world.
It will be updated every year, and each update has attracted the attention of urologists worldwide
.
Untreated metastatic urothelial carcinoma (mUC) can be divided into three types: suitable for patients with cisplatin-containing regimens, suitable for patients with carboplatin-containing regimens, and not suitable for patients with any platinum-containing regimens
.
This update of the 2021 EAU guidelines mainly involves first-line treatment, second-line treatment and above for metastatic urothelium
.
Download link: http://guide.
medlive.
cn/guideline/24467 Related reading: 2021 EAU Guidelines (Part 2): Second-line and above treatment of metastatic urothelial cancer; 2021 EAU guidelines | Metastatic urothelial cancer Treatment (Part I): First-line treatment of non-muscular invasive bladder cancer expert consensus on bladder perfusion therapy (2021 version) In recent years, the clinical diagnosis and treatment of non-muscular invasive bladder cancer at home and abroad has made great progress, including non-muscular invasive bladder cancer Risk assessment of bladder cancer, choice of bladder perfusion drugs, adverse reactions and treatment experience of bladder perfusion, and clinical research of new bladder perfusion drugs
.
The consensus is based on evidence-based medicine at home and abroad, combined with the current domestic clinical practice and application experience of bladder perfusion treatment for non-muscle invasive bladder cancer, and corresponding discussions and updates are carried out on the basis of the 2019 version of the expert consensus, with a view to improving the current domestic non-muscular invasive bladder cancer.
The clinical standardized treatment of bladder perfusion for muscular invasive bladder cancer provides certain guidance
.
Download link: http://guide.
medlive.
cn/guideline/24477 Chinese urothelial cancer human epidermal growth factor receptor 2 detection clinicopathological expert consensus At present, there is no internationally targeted urothelial cancer HER-2 expression status Standardize testing procedures and interpretation standards
.
The Oncology Pathology Professional Committee of the Chinese Anti-Cancer Association and the Urothelial Cancer Expert Committee of the Chinese Society of Clinical Oncology organize relevant experts based on the clinical practice of HER-2 expression, gene amplification and mutation detection in urothelial cancer, combined with current research progress, The committee members discussed internally, and finally reached a consensus of clinical pathology experts on the detection of human epidermal growth factor receptor 2 for urothelial cancer in China, aiming to standardize the detection standards of urothelial cancer HER-2 and improve the accuracy of interpretation to guide clinical applications
.
Download link: http://guide.
medlive.
cn/guideline/24489 Renal cancer bone metastasis clinical diagnosis and treatment expert consensus (2021 version) bone metastasis is a common metastatic site of kidney cancer, about 30% of metastatic renal cancer with bone metastasis, Bone-related events (SREs) occur in more than 70% of renal cancer patients with bone metastases.
Preventing the occurrence of SREs is one of the main goals of the treatment of renal cancer bone metastases
.
In addition to basic anti-tumor therapy, bone-modifying drugs are also the basic treatment for bone metastases from renal cancer
.
The expert group of the Professional Committee of Urinary and Male Reproductive System Tumors of the Chinese Anti-Cancer Association has reached a consensus to standardize the diagnosis and treatment model for bone metastases of kidney cancer in China, so as to improve the overall treatment level of bone metastases of kidney cancer and benefit more patients
.
Download link: http://guide.
medlive.
cn/guideline/244782021 ESMO clinical practice guide: the application of immunotherapy in early and advanced renal cell carcinoma (updated version) September 2021, the European Society of Medical Oncology (ESMO) released Guidelines for the application of immunotherapy in early and advanced renal cell carcinoma
.
The guidelines mainly focus on recent related content on immunotherapy for renal cell carcinoma
.
Download link: http://guide.
medlive.
cn/guideline/24271 Related reading: ESMO guide: A list of recommendations for early/advanced renal cell carcinoma immunotherapy! Expert consensus on the treatment of benign prostatic hyperplasia with traditional Chinese and Western medicine fusion medicine.
Chinese patent medicines for the treatment of benign prostatic hyperplasia combine syndrome differentiation and treatment with symptomatic treatment.
It has significant clinical effects in improving its symptoms and inhibiting benign prostatic hyperplasia, with obvious advantages
.
Although there are certain advantages in the treatment of BPH with integrated traditional Chinese and western medicine, there is a lack of standardized integrated Chinese and western medicine diagnosis and treatment plan, and the differentiation of syndromes is dogmatic.
It is difficult for western doctors who do not have the knowledge of traditional Chinese medicine to guide the use of Chinese patent medicines based on the consensus of traditional Chinese medicine.
Therefore, it is necessary to formulate This consensus
.
Download link: http://guide.
medlive.
cn/guideline/244632021 CUA Guidelines: Erectile Dysfunction In October 2021, the Canadian Urological Association (CUA) issued guidelines for erectile dysfunction
.
Erectile dysfunction (ED) affects the health and quality of life of patients.
The focus of evaluating ED patients is to determine the reversible and irreversible potential factors
.
This article mainly provides guidance and suggestions for the evaluation and treatment of ED
.
Download link: http://guide.
medlive.
cn/guideline/24336 Phimosis and overlength of the foreskin and foreskin-related diseases.
The consensus of Chinese experts and overlength of the foreskin accounts for a large proportion.
Circumcision is also the most common operation in urology and andrology.
One of them is traditional circumcision, ring ligation and suture circumcision.
Among them, ring ligation and suture circumcision have been widely developed and applied in domestic hospitals at all levels, but There are also problems such as irregular operation and over-treatment.
Standardized diagnosis, treatment and training are important measures to do a good job in circumcision and reduce surgical complications.
We are referring to relevant evidence-based medical clinical data, guidelines and consensus at home and abroad.
On the above, the consensus was compiled to provide appropriate clinical guidance and reference for the diagnosis and treatment of phimosis and foreskin-related diseases for urologists
.
Download link: http://guide.
medlive.
cn/guideline/24460 Chinese Expert Consensus on the Update of Standards for Screening Qualified Sperm Donor Volunteers Initiated with the Evaluation Professional Committee Sperm Bank and Reproductive Andrology Group, organized domestic experts in the field of human sperm bank to establish an expert consensus working group and discussed and wrote repeatedly
.
The content involves all aspects of the examination of sperm donors, including the choice of age, semen parameters, sperm morphological rate of sperm donors, supplementation of the physical examination standards for sperm volunteers, interpretation of 3 contents and 9 criteria for the examination results of sperm volunteers Point
.
Download link: http://guide.
medlive.
cn/guideline/243402021 ICCS consensus document: Neurodevelopmental disorders and urinary incontinence in children and adolescents-attention deficit/hyperactivity disorder, autism spectrum disorder and intellectual disability September 2021, The International Children’s Continence Society (ICCS) has issued a consensus document on neurodevelopmental disorders and urinary incontinence in children and adolescents.
Neurodevelopmental disorders (NDs) are a disabling disease that began to appear early in the statement, mainly due to genetic and neurobiological factors Cause, and have a tendency to persist
.
This article introduces the three most important NDs, including attention deficit/hyperactivity disorder, autism spectrum disorder, and intellectual disability
.
Download link: http://guide.
medlive.
cn/guideline/242522021 EAU Guidelines: Sexual and Reproductive Health-Male Infertility In September 2021, the European Association of Urology (EAU) updated and released the Men’s Sexual and Reproductive Health Guidelines Infertility related content
.
The content involves the epidemiology and pathology of male infertility, diagnostic tests, special considerations and management
.
Download link: http://guide.
medlive.
cn/guideline/24138
